FDA Inspection 1158424 — SGS Lab Simon

SGS Lab Simon — FEI 3004186644

The FDA completed an inspection of SGS Lab Simon on March 22, 2021 in Wavre. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 22, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wavre (Belgium)

Additional Details

Mutual Recognition Agreement (MRA)